News
Dupixent Gets FDA Approval for Eosinophilic Esophagitis
The approval was based on efficacy and safety data from a phase 3 trial, which included two 24-week treatment periods in patients 12 years of age and older with EoE.
Your search for proton pump inhibitor returned 2 results
Drugs in the Pipeline
Vonoprazan NDA Submitted for Erosive Esophagitis
The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis.
